1269232
USP
Famotidine Related Compound C
United States Pharmacopeia (USP) Reference Standard
别名:
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide monohydrochloride, 3-{[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio}-N-sulfamoylpropanamide hydrochloride
登录查看公司和协议定价
所有图片(1)
About This Item
推荐产品
生物源
synthetic
等級
pharmaceutical primary standard
agency
USP
API 家族
famotidine
形狀
powder
包裝
pkg of 25 mg
製造商/商標名
USP
儲存條件
protect from light
顏色
white to off-white
mp
298.4-314.6 °F (148—157°C)
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
2-8°C
InChI
1S/C8H14N6O3S3.ClH/c9-7(10)13-8-12-5(4-19-8)3-18-2-1-6(15)14-20(11,16)17;/h4H,1-3H2,(H,14,15)(H2,11,16,17)(H4,9,10,12,13);1H
InChI 密鑰
LBBLJRHWJZWHQA-UHFFFAOYSA-N
一般說明
Famotidine Related Compound C (Famotidine Impurity C) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
分析報告
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他說明
Sales restrictions may apply.
相關產品
产品编号
说明
价格
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
Journal of Separation Science, 31(2) (2008)
Famotidine
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
Talanta, 74(4) (2008)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Chromatographia, 60(7-8) (2004)
Potentiometric determination of famotidine in pharmaceutical formulations
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门